GLAXOSMITHKLINE, S.A. secures contract for Vaccines - Supply of the vaccine against the respiratory syncytial virus Arexvy exclusively from the pharmaceutical laboratory Glaxosmithkline, sa

Spain, July 1 -- Spain based GLAXOSMITHKLINE, S.A. has secured contract from Servicio Murciano de Salud - Junta de Compras for Vaccines - Supply of the vaccine against the respiratory syncytial virus Arexvy exclusively from the pharmaceutical laboratory Glaxosmithkline, sa . The value of the contract is worth 198000 EUR .

Published by HT Digital Content Services with permission from Pivotal Sources....